Cargando…

Emergence and Mechanism of Resistance of Tulathromycin Against Mycoplasma hyopneumoniae in a PK/PD Model and the Fitness Costs of 23S rRNA Mutants

Macrolides are widely used in diseases caused by Mycoplasma spp. The new semi-synthetic macrolide antibiotic tulathromycin is currently in wide use for the treatment of respiratory diseases of livestock. The objective of this study was to evaluate the antibacterial effect of tulathromycin against My...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Xirui, Yang, Lan, Ling, Yuzhou, Yu, Jiao, Ding, Huanzhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Veterinary Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873822/ https://www.ncbi.nlm.nih.gov/pubmed/35224081 http://dx.doi.org/10.3389/fvets.2022.801800

Ejemplares similares

The PK/PD Integration and Resistance of Tilmicosin against Mycoplasma hyopneumoniae
por: Huang, Zilong, et al.
Publicado: (2020)

Pharmacokinetic/Pharmacodynamic Relationships of Tulathromycin Against Actinobacillus pleuropneumoniae in a Porcine Tissue Cage Infection Model
por: Yao, Lihua, et al.
Publicado: (2022)

Chemotherapeutic Strategies with Valnemulin, Tilmicosin, and Tulathromycin to Control Mycoplasma hyopneumoniae Infection in Pigs
por: Stingelin, Giovani Marco, et al.
Publicado: (2022)

In vivo Pharmacokinetic/Pharmacodynamic (PK/PD) Profiles of Tulathromycin in an Experimental Intraperitoneal Haemophilus parasuis Infection Model in Neutropenic Guinea Pigs
por: Guo, Li-li, et al.
Publicado: (2021)

PK/PD integration of florfenicol alone and in combination with doxycycline against Riemerella anatipestifer
por: Zhang, Huilin, et al.
Publicado: (2022)

The PK/PD Interactions of Doxycycline against Mycoplasma gallisepticum
por: Zhang, Nan, et al.
Publicado: (2016)

Efficacy of a novel bivalent vaccine containing porcine circovirus type 2d and Mycoplasma hyopneumoniae against a dual PCV2d and Mycoplasma hyopneumoniae challenge
por: Ham, Sehyeong, et al.
Publicado: (2023)

Analysis of the mutant selection window and killing of Mycoplasma hyopneumoniae for doxycycline, tylosin, danofloxacin, tiamulin, and valnemulin
por: Huang, Zilong, et al.
Publicado: (2020)

Detection of Mycoplasma hyopneumoniae by polymerase chain reaction in swine presenting respiratory problems
por: Yamaguti, M., et al.
Publicado: (2008)

Construction of Mycoplasma hyopneumoniae P97 Null Mutants
por: Clampitt, Jeannett M., et al.
Publicado: (2021)

Kill Rate and Evaluation of Ex Vivo PK/PD Integration of Cefquinome Against Actinobacillus pleuropneumoniae
por: Zhang, Longfei, et al.
Publicado: (2021)

Pharmacokinetic/Pharmacodynamic Integration of Doxycycline Against Mycoplasma hyopneumoniae in an In Vitro Model
por: Zhang, Huilin, et al.
Publicado: (2019)

Characteristics of Mycoplasma hyopneumoniae Strain ES-2 Isolated From Chinese Native Black Pig Lungs
por: Zong, Bingbing, et al.
Publicado: (2022)

Pharmacokinetic/pharmacodynamic (PK/PD) evaluation of tulathromycin against Haemophilus parasuis in an experimental neutropenic guinea pig model
por: Zhao, Yongda, et al.
Publicado: (2018)

Selection of internal reference gene for normalization of reverse transcription-quantitative polymerase chain reaction analysis in Mycoplasma hyopneumoniae
por: Li, Shiyang, et al.
Publicado: (2022)

A Dual Swine Challenge With Porcine Circovirus Type 2 (PCV2) and Mycoplasma hyopneumoniae Used to Compare a Combination of Mixable Monovalent PCV2 and Monovalent M. hyopneumoniae Vaccines With a Ready-to Use PCV2 and M. hyopneumoniae Bivalent Vaccine
por: Yang, Siyeon, et al.
Publicado: (2020)

Pathogenicity & virulence of Mycoplasma hyopneumoniae
por: Leal Zimmer, Fernanda M. A., et al.
Publicado: (2020)

Pharmacodynamic Evaluation and PK/PD-Based Dose Prediction of Tulathromycin: A Potential New Indication for Streptococcus suis Infection
por: Zhou, Yu-Feng, et al.
Publicado: (2017)

The PK–PD Relationship and Resistance Development of Danofloxacin against Mycoplasma gallisepticum in An In Vivo Infection Model
por: Zhang, Nan, et al.
Publicado: (2017)

Relationship between danofloxacin PK/PD parameters and emergence and mechanism of resistance of Mycoplasma gallisepticum in In Vitro model
por: Zhang, Nan, et al.
Publicado: (2018)

Intrinsic terminators in Mycoplasma hyopneumoniae transcription
por: Fritsch, Tiago Ebert, et al.
Publicado: (2015)

Selective medium for culture of Mycoplasma hyopneumoniae
por: Cook, Beth S., et al.
Publicado: (2016)

Control of Mycoplasma hyopneumoniae infections in pigs
por: Maes, D., et al.
Publicado: (2008)

Tn-sequencing of Mycoplasma hyopneumoniae and Mycoplasma hyorhinis mutant libraries reveals non-essential genes of porcine mycoplasmas differing in pathogenicity
por: Trueeb, Bettina S., et al.
Publicado: (2019)

Attenuation of Mycoplasma hyopneumoniae Strain ES-2 and Comparative Genomic Analysis of ES-2 and Its Attenuated Form ES-2L
por: Li, Zhenya, et al.
Publicado: (2021)

Efficacy Evaluation of a Bivalent Vaccine Containing Porcine Circovirus Type 2b and Mycoplasma hyopneumoniae Against an Experimental Dual Challenge
por: Ahn, Yongjun, et al.
Publicado: (2021)

In vitro Elution of Penicillin, Ampicillin, Tetracycline, Tulathromycin, and Florfenicol From Plaster of Paris Beads
por: Merkatoris, Paul, et al.
Publicado: (2020)

Tulathromycin metaphylaxis increases nasopharyngeal isolation of multidrug resistant Mannheimia haemolytica in stocker heifers
por: Crosby, William B., et al.
Publicado: (2023)

Pharmacodynamic Parameters of Pharmacokinetic/Pharmacodynamic (PK/PD) Integration Models
por: Zhang, Longfei, et al.
Publicado: (2022)

Repetitive Elements in Mycoplasma hyopneumoniae Transcriptional Regulation
por: Cattani, Amanda Malvessi, et al.
Publicado: (2016)

Extracellular Actin Is a Receptor for Mycoplasma hyopneumoniae
por: Raymond, Benjamin B. A., et al.
Publicado: (2018)

Perspectives for improvement of Mycoplasma hyopneumoniae vaccines in pigs
por: Maes, Dominiek, et al.
Publicado: (2021)

Comparative efficacy of tulathromycin and tildipirosin for the treatment of experimental Mycoplasma bovis infection in calves
por: Bartram, David J., et al.
Publicado: (2016)

Discovery of Predictors of Mycoplasma hyopneumoniae Vaccine Response Efficiency in Pigs: 16S rRNA Gene Fecal Microbiota Analysis
por: Munyaka, Peris M., et al.
Publicado: (2020)

Proteogenomic mapping of Mycoplasma hyopneumoniae virulent strain 232
por: Pendarvis, Ken, et al.
Publicado: (2014)

MLVA typing of Mycoplasma hyopneumoniae bacterins and field strains
por: Tamiozzo, P., et al.
Publicado: (2015)

Survey on Mycoplasma hyopneumoniae gilt acclimation practices in Europe
por: Garza-Moreno, Laura, et al.
Publicado: (2017)

Current perspectives on the diagnosis and epidemiology of Mycoplasma hyopneumoniae infection
por: Sibila, Marina, et al.
Publicado: (2009)

Influence of pig gut microbiota on Mycoplasma hyopneumoniae susceptibility
por: Surendran Nair, Meera, et al.
Publicado: (2019)

Genotyping and biofilm formation of Mycoplasma hyopneumoniae and their association with virulence
por: Wu, Yuzi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p7uunjmaai426vp371c2q9i18u